These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 27438128)

  • 1. Access to fracture risk assessment by FRAX and linked National Osteoporosis Guideline Group (NOGG) guidance in the UK-an analysis of anonymous website activity.
    McCloskey EV; Johansson H; Harvey NC; Compston J; Kanis JA
    Osteoporos Int; 2017 Jan; 28(1):71-76. PubMed ID: 27438128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance of the Brazilian Fracture Assessment Risk Tool (FRAX) model and the age-dependent intervention thresholds according to National Osteoporosis Guideline Group (NOGG) guidelines on fracture prediction in community-dwelling older adults: the São Paulo Ageing and Health (SPAH) Study.
    Freitas TQ; Olalla LFG; Machado LG; Figueiredo CP; Takayama L; de Falco Caparbo V; Domiciano DS; Pereira RMR
    Arch Osteoporos; 2024 Jul; 19(1):59. PubMed ID: 38990403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of UK National Guidelines based on FRAX®--comparison with current clinical practice.
    Crabtree NJ; Bebbington NA; Chapman DM; Wahid YS; Ayuk J; Boivin CM; Cooper MS; Gittoes NJ;
    Clin Endocrinol (Oxf); 2010 Oct; 73(4):452-6. PubMed ID: 20626412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of clinical risk factors for osteoporosis and applicability of the FRAX tool in Joinville City, Southern Brazil.
    Silva DMW; Borba VZC; Kanis JA
    Arch Osteoporos; 2017 Dec; 12(1):111. PubMed ID: 29224172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting fracture risk in osteoporosis: the use of fracture prediction tools in an osteoporosis clinic population.
    Aw D; Thain J; Ali A; Aung T; Chua WM; Sahota O; Weerasuriya N; Marshall L; Kearney F; Masud T
    Postgrad Med J; 2016 May; 92(1087):267-70. PubMed ID: 26792635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A systematic review of intervention thresholds based on FRAX : A report prepared for the National Osteoporosis Guideline Group and the International Osteoporosis Foundation.
    Kanis JA; Harvey NC; Cooper C; Johansson H; Odén A; McCloskey EV;
    Arch Osteoporos; 2016 Dec; 11(1):25. PubMed ID: 27465509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of case-finding strategies in the UK for the management of hip fractures.
    Johansson H; Kanis JA; Oden A; Compston J; McCloskey E
    Osteoporos Int; 2012 Mar; 23(3):907-15. PubMed ID: 22234810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance of FRAX and FRAX-Based Treatment Thresholds in Women Aged 40 Years and Older: The Manitoba BMD Registry.
    Crandall CJ; Schousboe JT; Morin SN; Lix LM; Leslie W
    J Bone Miner Res; 2019 Aug; 34(8):1419-1427. PubMed ID: 30920022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Usefulness of FRAX tool for the management of osteoporosis in the Spanish female population].
    Azagra Ledesma R; Prieto-Alhambra D; Encabo Duró G; Casado Burgos E; Aguyé Batista A; Díez-Pérez A;
    Med Clin (Barc); 2011 May; 136(14):613-9. PubMed ID: 21349558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Global impact of COVID-19 on non-communicable disease management: descriptive analysis of access to FRAX fracture risk online tool for prevention of osteoporotic fractures.
    McCloskey EV; Harvey NC; Johansson H; Lorentzon M; Vandenput L; Liu E; Kanis JA
    Osteoporos Int; 2021 Jan; 32(1):39-46. PubMed ID: 33057738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Worldwide Fracture Prediction.
    El-Hajj Fuleihan G; Chakhtoura M; Cauley JA; Chamoun N
    J Clin Densitom; 2017; 20(3):397-424. PubMed ID: 28734709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative study between the implementation of the FRIDEX calibration and the NOGG guideline in the management of osteoporosis in routine clinical practice.
    Kyriakos G; Vidal-Casariego A; Quiles-Sánchez LV; Calleja-Fernández A; Ávila-Turcios D; Urosa-Maggi JA; Ballesteros-Pomar MD; Cano-Rodríguez I
    Reumatol Clin; 2017; 13(5):258-263. PubMed ID: 27373582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of the NOGG and NOF Guidelines on the Indication of Bone Mineral Density in Routine Clinical Practice.
    Kyriakos G; Vidal-Casariego A; Fernández-Martínez MN; Blanco-Suárez MD; Ballesteros-Pomar MD; Cano-Rodríguez I
    J Clin Densitom; 2015; 18(4):533-8. PubMed ID: 26343823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FRAX-based assessment and intervention thresholds--an exploration of thresholds in women aged 50 years and older in the UK.
    McCloskey E; Kanis JA; Johansson H; Harvey N; Odén A; Cooper A; Cooper C; Francis RM; Reid DM; Marsh D; Selby P; Thompson F; Hewitt S; Compston J
    Osteoporos Int; 2015 Aug; 26(8):2091-9. PubMed ID: 26077380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temporal changes in access to FRAX® in Thailand between 2010 and 2018.
    Chotiyarnwong P; Harvey NC; Johansson H; Liu E; Lorentzen M; Kanis JA; McCloskey EV
    Arch Osteoporos; 2019 Jun; 14(1):66. PubMed ID: 31227921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An assessment of intervention thresholds for very high fracture risk applied to the NOGG guidelines : A report for the National Osteoporosis Guideline Group (NOGG).
    Kanis JA; Johansson H; Harvey NC; Lorentzon M; Liu E; Vandenput L; McCloskey EV
    Osteoporos Int; 2021 Oct; 32(10):1951-1960. PubMed ID: 33813622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of strategies for setting intervention thresholds for Chinese postmenopausal women using the FRAX model.
    Liu SY; Huang M; Chen R; Ding N; Liu H; Xie ZJ; Sheng ZF; Luo BH; Ou YN
    Endocrine; 2019 Jul; 65(1):200-206. PubMed ID: 31111436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance of FRAX in clinical practice according to sex and osteoporosis definitions: the Manitoba BMD registry.
    Leslie WD; Majumdar SR; Morin SN; Lix LM; Schousboe JT; Ensrud KE; Johansson H; McCloskey EV; Kanis JA
    Osteoporos Int; 2018 Mar; 29(3):759-767. PubMed ID: 29404625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FRAX calculated without BMD does not correctly identify Caucasian men with densitometric evidence of osteoporosis.
    Hamdy RC; Seier E; Whalen K; Clark WA; Hicks K; Piggee TB
    Osteoporos Int; 2018 Apr; 29(4):947-952. PubMed ID: 29397409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting the 10-year risk of hip and major osteoporotic fracture in rheumatoid arthritis and in the general population: an independent validation and update of UK FRAX without bone mineral density.
    Klop C; de Vries F; Bijlsma JW; Leufkens HG; Welsing PM
    Ann Rheum Dis; 2016 Dec; 75(12):2095-2100. PubMed ID: 26984006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.